Stepan (SCL) recently reported second quarter 2026 results, with sales of US$684.11 million and net income of US$22.91 million. At the same time, the company affirmed a quarterly cash dividend of US$0.395 per share.

Stepan's earnings report and dividend affirmation have arrived alongside a period of stronger momentum, with a 30 day share price return of 13.18% and a year to date share price return of 35.62%. However, the 3 year total shareholder return is still down 26.23%.

If Stepan's recent move has you looking beyond chemicals, this could be a good moment to scan the market for other potential opportunities using the 20 top founder-led companies

After Stepan's sharp rebound and affirmed dividend, the choice now is between leaning into this renewed strength or waiting for a pullback. The next step is to see what the current valuation really implies.

Preferred Price-to-Sales Multiple for Stepan: Is it justified?

Stepan last closed at $63.96, and on a P/S basis the stock is currently valued at roughly 0.6x its revenue. That level sits below both the peer group and the broader US chemicals industry.

The price to sales ratio compares Stepan's market value to its annual revenue and can be a useful cross check when earnings are weak or negative. In this case, the company is currently unprofitable, yet the market price implies investors are paying a lower revenue multiple than for many similar chemical stocks.

According to the Simply Wall St checks, Stepan's 0.6x P/S is below the peer average of 1.2x and the US chemicals industry average of 1.1x. The fair P/S ratio estimate also sits at 0.6x. This is in line with the current level and suggests the market is broadly pricing the stock where the regression based fair multiple implies it could trade if sentiment moved closer to fundamentals.

Result: Price-to-Sales of 0.6x (UNDERVALUED)

However, Stepan still carries risks, including recent net income losses and a multi year shareholder return that is down, which could pressure sentiment if conditions weaken.

Another view on Stepan's valuation

While the P/S check suggests Stepan is trading in line with its fair ratio at 0.6x, the SWS DCF model paints a different picture. With the stock at $63.96 and the DCF value at $163.25, this approach points to a large undervaluation. Which signal do you trust more?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Stepan for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Stepan showing both fresh momentum and some lingering scars, it makes sense to review the facts for yourself and act promptly on your own judgment. To weigh both sides in one place, start with the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Stepan?

If Stepan has sharpened your focus, do not stop here. Broader context from other stocks can help you test your thinking and refine your next move.

• Target income strength by reviewing companies in the 9 dividend fortresses and see which payouts align with your risk comfort.
• Spot potential value opportunities by scanning the 51 high quality undervalued stocks that pair quality fundamentals with pricing that may warrant a closer look.
• Put capital resilience first by filtering for businesses in the 78 resilient stocks with low risk scores that score well on stability and downside protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.